Raymond Anderson

Filings by Raymond Anderson span 2 companies, the busiest being Monopar Therapeutics and Raptor Pharmaceutical Corp. The record holds 27 filings, for trades running from 23 June 2016 to 25 August 2026.

Sales make up the whole of the open-market record (6 sales, €602k). Other entries cover 1 share grant and 18 option exercises. So far in 2026, the count stands at no purchases and 6 sales.

The latest filing, published on 28 August 2026, reports an option exercise of €36k in Monopar Therapeutics. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.